Skip to content

Investment Resources

  • Blog

Kyle Dennis FDA Insider Alert | How to Trade Around Biotechs Earnings Announcements

May 29, 2019 by John Gladston

Earnings season is one of the busiest times for trading… and it happens 4 times a year… and typically, there’s a lot of volatility in stocks reporting earnings. Now, that’s good news for us because it uncovers a lot of trading opportunities.

However, when companies report earnings you need to know what to look for depending on which stocks you’re trading.

Generally, companies report revenues and earnings… and they’re compared to either previous earnings or analyst estimates, as well as guidance and other key pieces of information.

Now, depending on the sector and market capitalization… traders will focus on different metrics.

That said, let’s take a look at some of the key metrics to focus on when you’re looking to trade biotech earnings stocks… but first, we have to explain how earnings reports work.

Table of Contents

  • 1 Earnings Season Explained
  • 2 What to Focus on in Earnings Reports
  • 3 What to Focus on for Small-Cap Biotech Earnings
    • 3.1 Related

Earnings Season Explained

Keep in mind, I rarely buy stock or options and hold them into earnings… if I do, that means I really like the other factors I’m looking at, such as the chart pattern or overall changes in the company.

Now, earnings season happens a few weeks after each quarter end. You’ll see thousands of stocks reporting earnings in January – February, April – May, July – August, and October – November.

That said, we’re just winding down from our second earnings season of the year… and I’ve been getting questions about how to analyze earnings reports… and what to look for in small cap biotech stocks when they report earnings.

What to Focus on in Earnings Reports

For the most part, mid- and large-cap stocks focus on the headline number… you’ll see something like Apple Inc (AAPL) reported March quarter earnings – beating analysts expectations… AAPL’s guidance for the quarter was higher than analysts expected

With mega-cap companies like AAPL, they get so much analyst coverage… so traders have an idea of what the market is looking for.

Now, if a company reports guidance… that’s great… because the market is forward-looking… and guidance gives us an idea of where the company is headed.

When you look at what AAPL did in relation to what Wall Street expected, you could probably guess the stock went higher:

  • “EPS: $2.46 vs. $2.36 forecast by Refinitiv consensus estimates
  • Revenue: $58.02 billion vs. $57.37 billion forecast by Refinitiv consensus estimates
  • Q2 iPhone revenue: $31.05 billion vs. $31.10 billion expected forecast by FactSet consensus estimates
  • Q2 services revenue: $11.45 billion vs. $11.37 billion forecast by FactSet consensus estimates
  • Projected Q3 revenue: $52.5 to $54.5 billion vs. $51.94 billion forecast by Refinitiv consensus estimates”

For example, traders can compare the earnings per share (EPS) – the portion of a company’s profit allocated to each outstanding share (the bottom line) to analyst expectations.

Additionally, we could compare revenues (the amount of money the company actually made before discounting any expenses) to analyst estimates.

When a company’s actual numbers are higher than analyst estimates… and report strong guidance, chances are the stock will run higher… just like AAPL did.

Here’s what AAPL did the day after it reported these numbers.

With large companies, it’s a bit easier to analyze earnings because they’re actually selling products and services… if they’re selling more iPhones and services in the previous quarter and expect to see strong demand in the next quarter… the stock would probably gap up and run higher.

Additionally, we have a guide of what to expect from analysts.

However, what happens if a company doesn’t get a lot of analyst coverage and doesn’t report earnings?

For example, I trade small-cap biotech stocks a lot… these companies typically don’t get a lot of love from Wall Street… and generally, we don’t have any numbers to compare earnings or revenues to.

That said, I don’t really focus on looking at the top and bottom line… I focus on other metrics for this sector.

What to Focus on for Small-Cap Biotech Earnings

With small-cap biotechs, people don’t really care about the EPS or revenues… because they don’t sell anything yet. These companies are usually in their early stages and focused on researching and developing (R&D) treatments.

What they look for are drug pipeline updates.

In other words, traders are looking for key data points for treatments in the clinical trial stages. This allows traders to evaluate the overall potential for growth in revenues and earnings. Now, if you need a refresher on why clinical trials are so important for biotech stocks, check out my free eBook here.

Any updates on clinical trials actually uncover opportunities for us.

For example, let’s say you like the chart on a small cap biotech stock that just reported earnings… however, the company didn’t really move on the headline numbers… and they didn’t release any key data points for treatments in its pipeline.

The only thing they let investors know was the fact it was looking to release data for one of its treatments.

Well, you might think that the information wasn’t useful.

But if you know about my catalyst runup strategy, that actually could’ve helped you lock in a winner.

For example, I was watching VtV Therapeutics (VTVT), and I let clients know about my trading plan.

VtV Therapeutics (VTVT)

Catalyst Dates: Phase 2 Type 1 diabetes data due in June

Buy Zone: $1.25 to $1.50

Stop Zone: $1.10 or below

Now, VTVT reported earnings, and reiterated it would be reporting data in June… I liked the way VTVT was bouncing off a key support level… and chances are, the stock was going to get a nice runup into the data release.

That said, you can really use any details about treatments to uncover trading opportunities.

For example, I actually traded VTVT based on this pipeline update… and even alerted clients about the trade.

(Think my trading plans and alerts could benefit your trading?  Click here to find out how you can get them delivered to your inbox and phone) 

Keep in mind, I’m generally looking to hold these trades anywhere between 1-4 weeks.

Now, not too long after I bought shares of VTVT, it was running up in the after hours one day… and I actually took some profits off the table.

(If you want to receive real-time alerts like these,  click here to get started)

As you can see, updates on treatment pipelines could be very lucrative. However, you should understand how biotechs trade first… if you want to cut that learning curve,  click here to get started.

[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.

To learn more JOIN THIS SPECIAL ONLINE EVENT: 3-Step Plan Kyle Used to Turn $15,253 into $2,855,475 and download his FREE “The $2.9 Million Biotech Trader Playbook here!]

Source: BiotechBreakouts.com | Original Link

Related

Categories Kyle Dennis Biotech Breakouts Tags $100k Heist Live Event Kyle Dennis, $100k Heist Webinar Kyle Dennis, $100k Heist Webinar Registration Page, $100k Heist Webinar with Kyle Dennis, Biotech Breakouts, biotech breakouts kyle dennis review, biotech breakouts login, Biotech Breakouts Review, Biotech Breakouts reviews, Biotech Breakouts scam, Biotech Breakouts Stock Alerts Service Review, Biotech Breakouts Stock Alerts Service Scam, Biotech Nucleus, Biotech Nucleus Cost, Biotech Nucleus Customer Review, Biotech Nucleus Good, Biotech Nucleus Kyle, Biotech Nucleus Kyle Dennis, Biotech Nucleus Legit, Biotech Nucleus Real Member Review, Biotech Nucleus Review, Biotech Nucleus Reviews, Biotech Nucleus Scam, Biotech Nucleus User experience, Black Optics Review, Black Optics Reviews, Black Optics Scam, Black Optics Trading Program, Black Optics Trading Strategy, Black Optics Trading System, FDA Insider & Lightning Alerts, FDA Insider & Lightning Alerts Kyle Dennis, FDA Insider & Lightning Alerts Review, FDA Insider & Lightning Alerts Reviews, FDA Insider & Lightning Alerts Scam, FDA Insider Alert Free, FDA Insider Alert review, FDA Insider Alert reviews, FDA Insider Alert scam, fda insider alerts, How to turn $5K into $100K, How YOU Could "Steal" $100k From Wall Street, I.G.N.I.T.E., I.G.N.I.T.E. Options Kyle Dennis, I.G.N.I.T.E. Options Strategy, I.G.N.I.T.E. Options Strategy Kyle Dennis, I.G.N.I.T.E. Review, Join The Heist, kyle biotech breakouts, Kyle Dennis, Kyle Dennis Black Optics, Kyle Dennis Black Optics Complaints, Kyle Dennis Black Optics Fraud, Kyle Dennis Black Optics Login, Kyle Dennis Black Optics Performance, Kyle Dennis Black Optics Program, Kyle Dennis Black Optics Refund, Kyle Dennis Black Optics Results, Kyle Dennis Black Optics Review, Kyle Dennis Black Optics Reviews, Kyle Dennis Black Optics Scam, Kyle Dennis Black Optics System, Kyle Dennis Black Optics Website, Kyle Dennis FDA Insider & Lightning Alerts, Kyle Dennis FDA Insider & Lightning Alerts Review, Kyle Dennis FDA Insider & Lightning Alerts Scam, Kyle Dennis FDA Insider Alert review, Kyle Dennis fda insider alerts, Kyle Dennis fda insider alerts review, Kyle Dennis fda insider alerts scam, Kyle Dennis lightning alerts, Kyle Dennis lightning alerts review, Kyle Dennis lightning alerts scam, Kyle Dennis review, Kyle Dennis scam, Kyle Dennis Stocks, Kyle Dennis Stocks review, Kyle Dennis Stocks scam, Lightning Alerts Free, Lightning Alerts Review, Lightning Alerts Reviews, Lightning Alerts Scam, Middle-Class Millionaire Kyle Dennis, Middle-Class Millionaire: From $80K in Debt to $3M in Profits through Catalyst Trading, Option Rocket Kyle Dennis, Option Rocket Review, Option Rocket Reviews, Option Rocket Scam, Options Rocket Kyle Dennis, Options Rocket login, Options Rocket Review, Options Rocket Reviews, Options Rocket Scam, Options Rocket User experience, Options Rocket user review, Options Rocket webinar, Options Rocket website, The Heist, The Heist Kyle Dennis, The Heist Review, The Heist Scam
Jeff Bishop Weekly Money Multiplier | Profiting Off the Trade War
Palm Beach Confidential editor Teeka Tiwari is Hosting Live AMA (Ask Me Anything) on Crypto

Marc Chaikin Prediction - Top Stocks to Buy in 2024

Marc Chaikin Prediction

Join our list

2023 Wealth Protection Kit

Investment in Gold or Silver

“Get The FREE 2023 Wealth Protection Kit Americans Are Using To Protect Their Retirement Savings” – Sean Hannity

Click Here to Request Your Free Guide

Top 7 Trading Resources

Best Trading Advice

Steady Income Investments

Crypto News

Options Trading Strategies

Top Marijuana Stocks

FREE Trade Alerts

Best Blockchain Stocks to Buy

© 2023 Investment Resources • Built with GeneratePress